Glucocorticoid Use Tied to CVD Risk in Immune-Mediated Diseases
For patients with six immune-mediated inflammatory diseases, the risk for CVD is increased in association with glucocorticoid dose.
Inflammation
Ruxolitinib Not Beneficial for COVID-19-Associated Cytokine Storm
A phase 3 study evaluating the efficacy and safety of ruxolitinib for the treatment of COVID-19 did not meet its primary end point.
Baricitinib May Reduce Inflammation, Improve Outcomes in Patients With COVID-19
Researchers evaluated the clinical effect of baricitinib on mortality and morbidity in patients with COVID-19.
Software Can Determine Inflammation in Uveitis
Investigators compared automated imaging measures of inflammation with clinical exam assessment of activity in uveitis patients to determine efficacy.
Neurologic Manifestations of COVID-19 May Involve Cytokine Release Syndrome
Neurologic disturbances in patients with coronavirus disease 2019 were accompanied by evidence of cytokine release syndrome.
CDC Reports Cases of Multisystem Inflammatory Syndrome in Adults
Adult patients with current or previous SARS-CoV-2 can develop a hyperinflammatory syndrome.
Progression to Inflammatory Arthritis Associated With Autoantibody Positivity in First-Degree Relatives With RA
Researchers identified factors related to autoantibody positivity and development of inflammatory arthritis/rheumatoid arthritis, based on family history of disease.
Phenotype of COVID-19-Associated Hyperinflammation Linked to Escalation of Respiratory Support, Survival
Researchers evaluated a specific phenotype of COVID-19-associated hyperinflammation and its association with escalation of patient care.
Clinical, Radiologic Differences Observed Between Lung Involvement in Macrophage Activation Syndrome and Severe COVID-19
Researchers assessed clinical and laboratory data of patients with lung involvement in macrophage activation syndrome and severe COVID-19.
Can SARS-CoV-2 Infection Accelerate the Onset of an Autoimmune Disease?
Researchers evaluated the possibility of SARS-CoV-2 infection accelerating the onset of an autoimmune rheumatic disease.
-
Loading...
-
Loading...
Next post in General Rheumatology
